This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 May 16;385(9981):1920-2.

doi: 10.1016/S0140-6736(14)62482-X. Epub 2015 Apr 27.

A new ASPECT for complicated urinary tract infections

Jasper Fuk-Woo Chan¹, Kwok-Yung Yuen²

Affiliations

Affiliations

¹ State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China. Electronic address: jfwchan@hku.hk.
² State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.

PMID: 25931245
DOI: 10.1016/S0140-6736(14)62482-X

Comment

A new ASPECT for complicated urinary tract infections

Jasper Fuk-Woo Chan et al. Lancet. 2015.

. 2015 May 16;385(9981):1920-2.

doi: 10.1016/S0140-6736(14)62482-X. Epub 2015 Apr 27.

Authors

Jasper Fuk-Woo Chan¹, Kwok-Yung Yuen²

Affiliations

¹ State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China. Electronic address: jfwchan@hku.hk.
² State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.

PMID: 25931245
DOI: 10.1016/S0140-6736(14)62482-X

No abstract available

PubMed Disclaimer

Comment on

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Wagenlehner FM, Umeh O, Steenbergen J, Yuan G, Darouiche RO. Wagenlehner FM, et al. Lancet. 2015 May 16;385(9981):1949-56. doi: 10.1016/S0140-6736(14)62220-0. Epub 2015 Apr 27. Lancet. 2015. PMID: 25931244 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information